NASDAQ · IXHL
Incannex Healthcare Limited
$2.58-$0.13 (-4.8%)
Incannex Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 82.7% below the high.
Loading market information…
ASX · EPN.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 04:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Epsilon Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Epsilon Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufacturing and distributing a range of hydroponic supplies, including equipment, materials, and vital nutrients; developing and providing medicinal cannabis products; and offering comprehensive, ready-to-implement solutions for cannabis cultivation. The company officially rebranded from THC Global Group Limited to Epsilon Healthcare Limited in February 2021.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.58-$0.13 (-4.8%)
Incannex Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 82.7% below the high.
A$0.04-A$0.00 (-6.98%)
Rhinomed Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
A$0.05A$0.00 (0.0%)
Hygrovest Limited’s quoted price sits in the upper half of its reported 52-week range, 12.73% below the high.
A$0.02A$0.00 (0.0%)
Ecofibre Limited’s quoted price sits in the lower half of its reported 52-week range, 77.01% below the high.
A$0.04A$0.00 (0.0%)
Genetic Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 78.92% below the high.
A$0.02A$0.00 (0.0%)
Cann Global Limited’s quoted price sits in the lower half of its reported 52-week range, 27.59% below the high.
A$0.02A$0.00 (0.0%)
Opyl Limited’s quoted price sits in the lower half of its reported 52-week range, 38.89% below the high.
A$0.02A$0.00 (0.0%)
Bod Science Limited’s quoted price sits in the lower half of its reported 52-week range, 11.11% below the high.
